Metformin induced a significant reduction in anti-TPO Ab and anti-TG Ab levels in patients with HT and SCH (203), reduced TSH levels, and increased FT4 and FT3 levels in euthyroid patients with uninodular thyroid disease and insulin resistance (204). This evidence concerns the gene TPO and hematocrit.